CymaBay Therapeutics Strengthens Management Team with Appointment of Janet Dorling as Chief Commercial Officer

NEXT STORY
SELLAS Announces Completion of Enrollment in Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In Situ (DCIS) of the Breast
PREV STORY
Influenza Diagnostic Tests Market to hit $1.5 billion by 2025: Global Market Insights, Inc.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD

author_avatar
NASDAQ Market News

Extract Labs Named as Presenting Sponsor of Boulder’s First-Ever Foothills to Downtown Finish Line Marathon

author_avatar
NASDAQ Market News

Curis Reports Third Quarter 2016 Financial Results

LEXINGTON, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company ...

author_avatar
NASDAQ Market News